Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | CDC25B | P30305 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | TP53 | P04637 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.36 |
| ▸ | GFER | P55789 | 1/20 | 0.36 |
| ▸ | NGLY1 | Q96IV0 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27384002 | 0.87 | KMT2A (0.43) | ALDH1A1CDC25BCYP3A4HPGDHSD17B10 | |
| SCHEMBL24372498 | 0.86 | DUSP3 (0.41) | ALDH1A1CDC25BCYP3A4HPGDHSD17B10 | |
| SCHEMBL27012261 | 0.86 | GSTP1 (0.34) | ALDH1A1CDC25BHPGDMAPTDUSP3 | |
| SCHEMBL27384003 | 0.85 | ALK (0.43) | ALDH1A1CYP3A4HPGDTSHRMAPT | |
| SCHEMBL27384004 | 0.83 | TP53 (0.44) | ALDH1A1CDC25BCYP3A4HPGDHSD17B10 | |
| SCHEMBL27383607 | 0.82 | HSP90AA1 (0.43) | ALDH1A1CDC25BCYP3A4HPGDHSD17B10 | |
| SCHEMBL30659226 | 0.79 | DUSP3 (0.48) | ALDH1A1HPGDHSD17B10TP53TSHR | |
| SCHEMBL17284963 | 0.79 | EPHX2 (0.44) | ALDH1A1CDC25BCYP3A4HPGDHSD17B10 | |
| SCHEMBL24651701 | 0.78 | EPHX2 (0.43) | ALDH1A1CDC25BHPGDHSD17B10TP53 | |
| SCHEMBL21795428 | 0.78 | ALDH1A1 (0.55) | ALDH1A1CYP3A4HPGDHSD17B10TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11678577-B2 | Organic electronic element comprising compound for organic electronic element and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-06-13 | — | — | US | disclosed |
| US-11678577-B2 | Organic electronic element comprising compound for organic electronic element and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2023-06-13 | — | — | US | disclosed |
| US-20220131090-A1 | ORGANIC ELECTRONIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2022-04-28 | — | — | US | disclosed |
| US-11063226-B1 | Organic electronic element comprising compound for organic electronic element and an electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2021-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11678577-B2 | Organic electronic element comprising compound for organic electronic element and an electronic device thereof | ESR1, EML4, OCIAD2 | ALDH1A1 757/4885CDC25B 1816/4885CYP3A4 348/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.